Article info
Clinical and epidemiological research
Concise report
What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort
- Correspondence to Dr Maya H Buch, Leeds Institute of Rheumatic & Musculoskeletal Medicine, 2nd Floor, Chapel Allerton Hospital, Chapeltown Road, Leeds, LS7 4SA, UK; m.buch{at}leeds.ac.uk
Citation
What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort
Publication history
- Received January 29, 2014
- Revised March 31, 2014
- Accepted May 1, 2014
- First published May 22, 2014.
Online issue publication
July 31, 2014
Article Versions
- Previous version (22 May 2014).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions